Atlas Trials

Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse ALL

Clinical trial NCT02766868 · UNKNOWN

Trial details

NCT number
NCT02766868
Sponsor
Shanghai Jiao Tong University School of Medicine
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoblastic Leukemia, Acute, Adult
Start date
2016-01-01
Primary completion
2019-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.